# Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1

> **NCT02171819** · PHASE1 · COMPLETED · sponsor: **Institute of Vaccines and Medical Biologicals, Vietnam** · enrollment: 75 (actual)

## Conditions studied

- Influenza A Subtype H5N1 Infection

## Interventions

- **BIOLOGICAL:** IVACFLU-A/H5N1, 7.5 mcg
- **BIOLOGICAL:** IVACFLU-A/H5N1, 15 mcg
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02171819
- **Lead sponsor:** Institute of Vaccines and Medical Biologicals, Vietnam
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171819, "Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02171819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*